We invest in emerging biotechnology companies developing transformative cancer medicines, with a focus on precision medicine. Our goal is to fuel the success of these companies worldwide by providing capital and strategic support through critical moments of scientific validation and value creation.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
60.9%United Kingdom
23.9%Philippines
4.3%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
No stages listed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Nextech VIII
$707M